A recent study by researchers at Brigham and Women's Hospital and Harvard Medical School, both based in Boston, found only 43% of cancer drugs granted accelerated FDA approval demonstrated clinical benefit in confirmatory trials.
Author: Mariah Taylor
Here are 100 hospitals and health systems that opened cancer centers or expanded cancer care services in 2024:
Approximately 81% of oncologists said patients should consent to artificial intelligence use for cancer treatment decisions, a recent survey found.
The Oncology Nursing Society honored five nurses and a cancer center for excellence.
Philadelphia-based Fox Chase Cancer Center has expanded to New Jersey with its first oncology office.
Advertisement
New York City-based NYU Langone Health's Perlmutter Cancer Center launched a phase 3 trial for its metastasis melanoma mRNA vaccine.
New York City-based NYC Health + Hospitals screened more than 50,000 patients for colorectal cancer in 2023 using an at-home fecal immunochemical test.
Little Rock-based University of Arkansas for Medical Sciences Winthrop P. Rockefeller Cancer Institute received an $11.48 million federal grant to create the Center for Molecular Interactions in Cancer.
A genetic test could stop some patients from overdosing on a chemotherapy drug, but only 3% of oncologists are testing patients, KFF Health News reported March 26.
Seattle-based Fred Hutchinson Cancer Center researchers found a blood test could detect colorectal cancer with 83.1% accuracy.